News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerecor Inc. to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum


10/2/2013 7:33:47 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Cerecor Inc., a biopharmaceutical company developing neuroscience drugs that make a difference in underserved patient segments of common diseases, today announced that Blake Paterson, MD, CEO and Co-Founder, will present a corporate overview, highlighting CERC-301, an oral rapid-acting antidepressant in clinical development for treatment-resistant depression, and its COMT inhibitor platform for the treatment of the cognitive impairment observed in many different conditions at the 12th Annual BIO Investor Forum in San Francisco, CA. The presentation will take place on Wednesday, October 9, 2013, at 2pm PT.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES